Bio-Rad Laboratories, Inc. (BIO.B)
NYSE · Common stock · Laboratory Analytical Instruments
As of Oct 21, 2:37 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
BIO.B trades thinly or has a short history, so some panels below have little to show.
Follow BIO.B in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on BIO.B and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
BIO.B at a glance
Key statistics
$9.74B
Market capitalization
- Previous close
- $364.15
- Open
- $357.92
- Day range
- $357.92 – $359.75
- Volume
- 8
- Average volume (30 sessions)
- 425
- Shares outstanding
- 5.06M
- Price / earnings
- 43.8
- Earnings per share
- $8.32
- Price / book
- 1.4
- Price / sales
- 3.8
Where the price sits in its year
52-week range
95% of the range
- Below the 52-week high
- -1.6%
- Above the 52-week low
- +46.8%
Completed sessions through Oct 14, 2026
Technical snapshot
Too little history for the longer averages yet.
- 20-day average
- $290.67+25.3%
- 50-day average
- —
- 200-day average
- —
Between the conventional 30 and 70 bands.
+24.1%
1 week
+35.4%
1 month
—
3 months
+17.2%
Year to date
—
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with BIO.B
BIO.B on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on BIO.B.
See the plans →
Every planScreen names like BIO.B
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on BIO.B
Put BIO.B on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on BIO.B
See whether there is an open premium alert on BIO.B, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
BIO.B headlines
- Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories
Benzinga · May 18, 2026
- North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
GlobeNewswire Inc. · Jul 29, 2025
SEC Form 4, most recent first
Insider filings
Lakkaraju Roop Kalyan
−559
EVP, Chief Financial Officer · Shares withheld for tax
$215.84K · Sep 5, 2026
DiVincenzo Jonathan P.
−1.7K
President & COO · Option exercise
· Sep 5, 2026
EVRAN SEDAT
−329
EVP, Global Supply Chain · Shares withheld for tax
$127.03K · Sep 5, 2026
ENGELHARDT EVA ANETTE
+4.3K
EVP, President, CDG · Grant or award
· Sep 4, 2026
Mehta Rajat
+1.4K
EVP, GBL Commercial Operations · Option exercise
· Sep 5, 2026
ENLOE COURTNEY C
+685
EVP, General Counsel & Sec · Option exercise
· Sep 5, 2026
BARRY JAMES
+1.1K
EVP, President, LSG · Option exercise
· Sep 6, 2026
SCHWARTZ NORMAN D
−3.5K
Chairman & CEO, Director, 10% owner · Option exercise
· Sep 6, 2026
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Hercules, CA
- Employees
- 7,450
- Listed since
- Jan 1, 1900
- Website
- bio-rad.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.